Cargando…

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone

To assess the rate and predictors of clinically meaningful improvements (CMI) in patients with lower urinary tract symptoms (LUTS) treated with either silodosin (SIL) alone or with a combination of SIL+ serenoa repens (Ser) hexanic lipidosterolic extract for ≥12 months. Data from 186 patients were c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeri, Luca, Capogrosso, Paolo, Ventimiglia, Eugenio, Cazzaniga, Walter, Pederzoli, Filippo, Moretti, Donatella, Dehò, Federico, Montanari, Emanuele, Montorsi, Francesco, Salonia, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680270/ https://www.ncbi.nlm.nih.gov/pubmed/29123161 http://dx.doi.org/10.1038/s41598-017-15435-0

Ejemplares similares

The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH
por: Roehrborn, C G, et al.
Publicado: (2011)

Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH – a double-blind randomized trial
por: Manohar, Chikka Moga Siddaiah, et al.
Publicado: (2017)

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020)

Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men
por: Boeri, Luca, et al.
Publicado: (2019)

Multiple PDE5Is use as a marker of decreased overall men’s health: A real-life study
por: Oreggia, Davide, et al.
Publicado: (2018)

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Focus on Silodosin: Pros and Cons of Uroselectivity
por: Califano, Gianluigi, et al.
Publicado: (2020)

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
por: Kaplan, Steven A, et al.
Publicado: (2011)

Correction to: Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

A Suspected Case of Silodosin-Induced Erythroderma
por: Liu, Annie, et al.
Publicado: (2015)

Silodosin-associated intraoperative floppy iris syndrome
por: Chatterjee, Samrat, et al.
Publicado: (2017)

Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
por: Rahman, Md Jawaid, et al.
Publicado: (2017)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction – A Case-Control Study
por: Boeri, Luca, et al.
Publicado: (2017)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
por: Yoshida, Masaki, et al.
Publicado: (2011)

Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
por: Sakata, Koichi, et al.
Publicado: (2012)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review
por: Jindan, Luo, et al.
Publicado: (2022)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
por: González-Álvarez, Isabel, et al.
Publicado: (2022)

Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle
por: Hennenberg, Martin, et al.
Publicado: (2012)

Orgasmic Dysfunction after Radical Prostatectomy
por: Capogrosso, Paolo, et al.
Publicado: (2017)

The Clinical Impact of Hexanic Extract of Serenoa repens in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study
por: Samarinas, Michael, et al.
Publicado: (2020)

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
por: Cho, Hee Ju, et al.
Publicado: (2014)

Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009)

Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study
por: Elgalaly, Hazem, et al.
Publicado: (2016)

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: A randomized controlled trial
por: Pande, Satabdi, et al.
Publicado: (2014)

The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis
por: Yang, Diandong, et al.
Publicado: (2016)

Use of Silodosin to Visualize the Posterior Urethra in Pelvic Floor Urethral Distraction Defect Patients
por: Ranjan, Nikhil, et al.
Publicado: (2015)

Medical Expulsive Therapy for Distal Ureteral Stones: Tamsulosin Versus Silodosin in the Turkish Population
por: Arda, Ersan, et al.
Publicado: (2017)

Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy
por: Karaca, Umut, et al.
Publicado: (2021)

Improvement in Near Vision Following Silodosin Treatment in Patients With Lower Urinary Tract Symptoms
por: Shin, Hyun Jin, et al.
Publicado: (2021)

Silodosin Improves Pain and Urinary Frequency in Bladder Pain Syndrome/Interstitial Cystitis Patients
por: Abreu-Mendes, Pedro, et al.
Publicado: (2022)

Successful treatment of ejaculation pain with silodosin in patient with Zinner syndrome: a case report
por: Uetani, Masato, et al.
Publicado: (2023)

A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus
por: Abdullah, Atif, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0t61ra1ljsggch95bg378g154c